Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Caliper; PerkinElmer; Becton Dickinson; iGenix; Intrexon; Genedata, Takeda; EMBL-EBI

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences said that its LabChip Dx instrument has received the CE IVD Mark, making the instrument available for use with clinical patient samples in Europe. The instrument was developed in collaboration with South Korean molecular diagnostics firm Seegene and runs assays developed by Seegene.

PerkinElmer said this week that its board of directors has declared a quarterly dividend of $.07 per share of common stock. The dividend is payable on Nov. 11, to shareholders of record as of the close of business on Oct. 21.

The board of directors of Becton Dickinson declared a quarterly dividend this week of $.41 per common share. The dividend is payable on Sept. 30, to shareholders of record on Sept. 9.

Molecular testing services firm iGenix has received a Medical Test Site license from the State of Washington for its first diagnostic assay run on Illumina's BeadXpress platform. The license means that the firm can now run the test, a multiplexed assay for common SNPs in CYP2C9 and VKORC1, in its CLIA lab for diagnostic purposes. The pharmacogenomic assay was built as a proof-of-principle test for CLIA certification, the Seattle-based company said, adding it is one of several in its R&D pipeline.

Synthetic biology firm Intrexon said this week that its AgBio division has recently expanded to a new location in Research Triangle Park, NC. The division moved to a 28,000 square-foot facility previously occupied by Athenix, a Bayer CropScience company.

Genedata said this week that Takeda Pharmaceutical has expanded its license to the firm's Expressionist software package for managing and analyzing mass spectrometry data.

The European Molecular Biology Laboratory's European Bioinformatics Institute has received a contract to run and lead development of UK PubMed Central (UKPMC), a free online literature resource for life science researchers. UKPMC includes more than two million full-text biomedical research articles, over 25 million citations from PubMed and Agricola, patents from the European Patent Office, UK treatment guidelines, and biomedical PhD theses. The resource now has 18 UK and European funders, led by the Wellcome Trust.